Brian Leyland und Oncology - Info zur Person

(1 - 15 von 16

)

News | SciTech Development | Fenretinide | ST-001 nanoFenretinidewww.scitechdevelopment.com › news

www.scitechdevelopment.com

SciTech Development Appoints Brian Leyland-Jones, MD, PhD as Chief Medical Officer · SciTech Development to Present at NYC Spring Oncology Investor ...

Anixa Biosciences Announces Formation of Breast Cancer ...PR Newswire

www.prnewswire.com

— Brian Leyland-Jones, MBBS, MD, Ph.D., FACP, FRCPC, is a pre-eminent clinical trialist in oncology and the recipient of numerous awards. He — Brian Leyland-Jones, MBBS, MD, Ph.D., FACP, FRCPC, is a pre-eminent clinical trialist in oncology and the recipient of numerous awards. He ...

Trastuzumab: hopes and realitiesThe Lancet

www.thelancet.com

Dr Brian Leyland-Jones. The Lancet Oncology. Volume 3 Issue 3 Pages (March 2002). DOI: S (02)

Leyland-Jones, Brian R, MD - Atlanta, GA Yellow Pageswww.yellowpages.com › GA › Atlanta › Doctors

www.yellowpages.com

Dr. Brian Leyland-Jones, MD. Categories. Physicians & Surgeons, Physicians & Surgeons, Hematology (Blood), Physicians & Surgeons, Oncology. View More ...

Brian leyland-jones Sanford Research · oncologyResearchGate

www.researchgate.net

Brian Leyland-Jones, MBBS, MD, Ph.D., FACP, FRCPCAnixa Biosciences, Inc. (ANIX)

www.anixa.com

Brian Leyland-Jones, MBBS, MD, Ph.D., FACP, FRCPC. Dr. Leyland-Jones is a pre-eminent clinical trialist in oncology and the recipient of numerous awards. Brian Leyland-Jones, MBBS, MD, Ph.D., FACP, FRCPC. Dr. Leyland-Jones is a pre-eminent clinical trialist in oncology and the recipient of numerous awards.

Brian Leyland-Jones, MBBS, PhDTargeted Oncology

www.targetedonc.com

Brian Leyland-Jones, MBBS, PhD, director of Edith Sanford Breast Cancer Research, discusses the results of the SWOG S0500 trial, which looked at circulating ... Brian Leyland-Jones, MBBS, PhD, director of Edith Sanford Breast Cancer Research, discusses the results of the SWOG S0500 trial, which looked at circulating ...

Nandini Dey Pradip De Brian Leyland-Jones EditorsBuchhandlung Schreiber

www.schreibers.ch

Brian Leyland-Jones. Avera Cancer Institute Center for Precision. Oncology. Sioux ... Carlson, Brian Leyland-Jones and Nandini Dey. 4 The AKT-mTOR Signaling ... Brian Leyland-Jones. Avera Cancer Institute Center for Precision. Oncology. Sioux ... Carlson, Brian Leyland-Jones and Nandini Dey. 4 The AKT-mTOR Signaling ...

ANNUAL REPORT 2021McGill University

www.mcgill.ca

Brian Leyland-Jones, the inaugural Chair of the Department of. Oncology, was the recipient of the Lifetime Achievement Award.

PI3K-mTOR in Cancer and Cancer Therapy | SpringerLinkSpringer

link.springer.com

von N Dey · Zitiert von: 8 — Brian Leyland-Jones, MB BS, Ph.D. is Vice President of Avera Cancer Institute Center for Precision Oncology. Dr. Leyland-Jones is a consulting professor at the ...

Looking Beyond Single-Drug Approaches to Precision Oncology ...www.illumina.com › science › customer-stories › lo...

www.illumina.com

Brian Leyland-Jones, MD, PhD is an oncologist/hematologist at the Avera Cancer Institute Center for Precision Oncology and Brandon Young is Director of ...

Interview with Dr. Brian Leyland-JonesCancerQuest

cancerquest.org

Interview with Dr. Brian Leyland-Jones. Brian Leyland-Jones sitting in an office. Professor, Department of Hematology and Medical Oncology Emory University ... Interview with Dr. Brian Leyland-Jones. Brian Leyland-Jones sitting in an office. Professor, Department of Hematology and Medical Oncology Emory University ...

Attrition of Patients on a Precision Oncology TrialNational Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von SS Bohan · · Zitiert von: 8 — ... Brian Leyland-Jones , Scott M Lippman , Razelle Kurzrock. Affiliations. 1 San Diego State University/University of California, San Diego, San Diego ... von SS Bohan · · Zitiert von: 8 — ... Brian Leyland-Jones , Scott M Lippman , Razelle Kurzrock. Affiliations. 1 San Diego State University/University of California, San Diego, San Diego ...

Stability of 5-acetamido-6-formylamino-3-methyluracil in ...National Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von P Wong · · Zitiert von: 26 — Brian Leyland-Jones. Affiliation. 1 Department of Oncology, McGill University, McIntyre Medical Science Building, Suite 701, Promenade Sir William Osler ... von P Wong · · Zitiert von: 26 — Brian Leyland-Jones. Affiliation. 1 Department of Oncology, McGill University, McIntyre Medical Science Building, Suite 701, Promenade Sir William Osler ...

Herceptin ® adjuvant therapy: “a triumphal narrative of ...SlidePlayer

slideplayer.com

Herceptin ® adjuvant therapy: “a triumphal narrative of translational research” Brian Leyland-Jones McGill University Department of Oncology Montreal,.

Alle Infos zum Namen "Brian Leyland"

Verwandte Suchanfragen zu Brian Leyland

Ross Mckitrick

Personen
Vorname "Brian" (12497)
Name "Leyland" (178)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Brian Leyland und Oncology Person-Info